Nanocochleate - a new approch in lipid drug delivery

International Journal of Pharmacy and Pharmaceutical Sciences

Volumn 2, Issue 4, 2010, Pages 220-223

  Ravi Sankar, V ^a   Dastagiri Reddy, Y ^a  

^a CES College of Pharmacy   (India)

Author keywords

Cationic drug; Hydrophilic; Hydrophobic; Liposomes; Nanocochleate

Indexed keywords

CATION; DRUG CARRIER; FLUORESCENT DYE; LIPID; LIPOSOME; METAL ION; NANOCOCHLEATE; PEPTIDE; SODIUM CHLORIDE; UNCLASSIFIED DRUG;

CELL INTERACTION; CELL SURFACE; DRUG DELIVERY SYSTEM; FIBROBLAST; HYDROGEL; MOLECULAR SIZE; REVIEW;

EID: 83455200692     PISSN: None     EISSN: 09751491     Source Type: Journal    
DOI: None     Document Type: Review

References (28)

1. Leone-Bay A, Paton DR, Weidner JJ. The development of delivery agents that facilitate the oral absorption of macromolecules drugs. Med Res Rev. 2000; 20(2):169-86.
2. Florence AT, Hussain N. Transcytosis of nanoparticle and dendrimer delivery systems: evolving vistas. Adv Drug Deliv Rev. 2001; 50; suppl.1:S69-S89.
3. Han HK, Amidon GL. Targeted prodrug design to optimize drug delivery. AAPS Pharm Sci. 2000;2(1):E6.
4. Modi P, Mihi M, Lewin A. The evolving role of oral insulin in the treatment of diabetes using a novel rapidmist (trade mark) system. Diabetes Metab Res Rev. 2002; 1; suppl.1:S38-S42.
5. Egan WJ, Lauri E. Prediction of intestinal permeability. Adv. Drug Del. Rev. 2002; 54, 273-289.
6. Salama NN. Tight junction modulation and its relationship to drug delivery. Adv. Drug Deliv. Rev. 2006; 58: 15-28.
7. Huang Y, Sadee W. Membrane transports and channels in chemo-resistance and sensitivity of tumor cells. Cancer Lett. 2006; 239: 181-182.
8. Morishita M, Peppas NA. Is the oral route possible for peptide and protein drug delivery? Drug Discov. Today. 2006; 11: 905-908.
9. Panchagnula R, Sood A. Peroral route: an opportunity for protein and peptide drug delivery. Chem. Rev. 2001;101: 3275-3304.
10. Helens H, Bentz J. Ph induced destabilization of phoshatidyl ethanolamine containing liposomes. Biochemistry. 1984; 23: 1532-1538.
11. Feng SS, Ruan G, Li Q. Fabrication and characterization of novel drug delivery device liposomes in microspheres (LIMs). Biomaterials. 2004; 25: 5181-5189.
12. Lu D, Huang L. Small but not large unilamellar liposomes composed of dioleoylphoshatidyl ethanolamine and oleic acid. Biochemistry. 1989; 28: 7700-7707.
13. Papahadjopoulos D, Wilschut J. Calcium induced fusion of phospholipids vehicles. Nature. 1979; 281: 690-692.
14. Elsayed MMA, Abdallah OY, Naggar VF, Khalafallah NM. Lipid vesicles for skin delivery of drugs: Reviewing three decades of research. Int. J. Pharm. 2007; 332: 1-16.
15. Sciences International). Sep. 30; 2003.
16. Zarif L, Graybill J, Perlin D, Mannino RJ. Cochleates: new lipidbased drug delivery system. J Liposome Res. 2000;10(4):523-38.
17. Zarif L. Cochleate in drug delivery (Invited Review, in preparation for Methods in Enzymology).
18. Popescu C, Franzblau S, Zarif L. Cochleates potentiate the efficacy of antibacterial drug, clofazimine. Abstract presented at 41st ICAAC December 16-19, 2001, in Chicago, IL.
19. Papahadjopoulos D, Vail WJ, Jacobson K,et al. Cochleate lipid cylinders: formation by fusion of unilamellar lipid vesicles. BioChem, Biophys Acta. 1975; 394(32):483-491.
20. Gould-Fogerite S, Kheiri M, Zhang F, et al. Targeting Immune response induction with cochleate and liposome-based vaccines. Adv Drug Deliv Rev. 1998; 3: 273-287.
21. Zarif L, Jin T, Segarra I, Mannino RJ. Novel hydrogel isolated cochleate formulations, process of preparation and their use for the delivery of pharmaceutical agents. PCT Application WO 01/52817 A2. Filed 1/22/2000 US 6,153,217.
22. Zarif L. Elongated supramolecular assemblies in drug delivery. J. Control. Rel. 2002; 81: 7-23.
23. Sampaio, J.L., Moreno, M.J., Vaz, W.L. Kinetics and thermodynamics of association of a fluorescent lysophospholipid derivative with lipid bilayers in liquidordered and liquid-disordered phases. Biophys. J. 2005; 88: 4064-4071.
24. Villa AM, Caporizzo E, Papagni A. Choline and phosphatidylcholine fluorescent derivatives localization in carcinoma cells studied by laser scanning confocal fluorescence microscopy. Eur. J. Cancer. 2005; 41: 1453-1459.
25. Delmas G, Chen WC, Tan F, et al Efficacy of orally delivered cochleates containing amphotericin B in a murine model of aspergillosis. Antimicrobial Agents and Chemotherapy. 2002; 46: 2704-2707.
26. Etcgroup. Down on the farm-The Impact of Nano-Scale Technologies on Food and Agriculture. Available at: http://www.etcgroup.org/. 2004.
27. Joseph T, Morrison M. Nanotechnology in agriculture and food: A nanoforum report. Institute of nanotechnology. Available at: http://www.nanoforum.org/. 2006.
28. Development of a Nanocochleate based ApoA1 Formulation for the Treatment of Atherosclerosis and other Coronary Heart Diseases. Available at pharmaceutical practical guide, Indigo pharma.